These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11831842)

  • 1. Patient perspective on zanamivir in the treatment of influenza.
    Bricaire F; Cohen JM; Jacquet M; Boucot I; Nicolas M;
    Int J Clin Pract; 2002; 56(1):7-10. PubMed ID: 11831842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
    J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
    Johny AA; Clark A; Price N; Carrington D; Oakhill A; Marks DI
    Bone Marrow Transplant; 2002 Jan; 29(2):113-5. PubMed ID: 11850704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
    Monto AS; Pichichero ME; Blanckenberg SJ; Ruuskanen O; Cooper C; Fleming DM; Kerr C
    J Infect Dis; 2002 Dec; 186(11):1582-8. PubMed ID: 12447733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug under test: influenza--Relenza in daily practice. Experience during the influenza season 1999/2000.
    Schmidt RE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):175-9. PubMed ID: 12458355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
    Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zanamivir. No noticeable progress against influenza.
    Can Fam Physician; 2000 Oct; 46():2003-8, 2012-8. PubMed ID: 11184246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zanamivir: from drug design to the clinic.
    Elliott M
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why not [symbol: see text]zanamivir?
    Drug Ther Bull; 2001 Feb; 39(2):9-10. PubMed ID: 11235064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
    Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA
    An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [symbol: see text] Zanamivir for influenza.
    Drug Ther Bull; 1999 Nov; 37(11):81-4. PubMed ID: 10696691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.
    Hirji Z; O'Grady S; Bonham J; Mak M; Takata-Shewchuk J; Hawkins K; Gardam M; Law L; Mazzulli T; Conly J
    Can Commun Dis Rep; 2001 Feb; 27(3):21-4. PubMed ID: 11227819
    [No Abstract]   [Full Text] [Related]  

  • 17. Zanamivir: new preparation. No tangible progress against influenza.
    Prescrire Int; 2000 Feb; 9(45):199-202. PubMed ID: 11503795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zanamivir: a second look. Still no tangible impact on influenza.
    Prescrire Int; 2001 Dec; 10(56):175-7. PubMed ID: 11824440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic predictors of influenza virus positivity in children during the influenza season.
    Ohmit SE; Monto AS
    Clin Infect Dis; 2006 Sep; 43(5):564-8. PubMed ID: 16886147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zanamivir for influenza virus infections.
    Adelman A
    J Fam Pract; 1998 Jan; 46(1):17-8. PubMed ID: 9451361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.